Verition Fund Management LLC Iveric Bio, Inc. Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $5.91 Million - $8.92 Million	225,146 New	225,146 $8.86 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $106,361 - $210,345	11,315 New	11,315 $203,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $1.2 Million - $1.63 Million	-86,710 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $613,039 - $1.52 Million	86,710 New	86,710 $1.41 Million
Q3 2020 Nov 16, 2020	SELL	$4.01 - $6.29 $221,753 - $347,837	-55,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $169,218 - $364,980	55,300 New	55,300 $282,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.